Development of an enzyme immunoassay to detect antibody to Chlamydia Pneumoniae strain twar and its application in a limited seroepidemiological survey

Peter G. Hallsworth, Steven L. Wesselingh, Peter J. McDonald

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A non-competitive enzyme immunoassay (EIA) was developed to detect IgG antibody to the recently-described species Chlamydia pneumoniae strain TWAR. Purified elementary bodies of the organism were used as capture antigen. Cross-reacting antibody to Chlamydia trachomatis was detected in the assay by running a parallel EIA for IgG antibody to C. trachomatis. The C. pneumoniae assay was validated by comparing the results on 60 selected sera with those obtained with the micro-immunofluorescence test. The comparison indicated that the EIA had a sensitivity of 88%, specificity of 100% and overall correlation with micro-immunofluorescence of 93%. The assay was applied to 352 sera from 3 populations within Australasia in a limited survey to determine the extent of exposure to this organism. Prevalence rates of up to 55% were found, suggesting that a significant amount of respiratory disease in the region may be due to C. pneumoniae strain TWAR.

Original languageEnglish
Pages (from-to)87-90
Number of pages4
JournalPathology
Volume24
Issue number2
DOIs
Publication statusPublished - 1992

Keywords

  • C. Pneumoniae
  • EIA

Fingerprint Dive into the research topics of 'Development of an enzyme immunoassay to detect antibody to Chlamydia Pneumoniae strain twar and its application in a limited seroepidemiological survey'. Together they form a unique fingerprint.

  • Cite this